Found: 72
Select item for more details and to access through your institution.
Prevalence of mcr-type genes among colistin-resistant Enterobacteriaceae collected in 2014-2016 as part of the INFORM global surveillance program.
- Published in:
- PLoS ONE, 2018, v. 13, n. 4, p. 1, doi. 10.1371/journal.pone.0195281
- By:
- Publication type:
- Article
In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes—Study for Monitoring Antimicrobial Resistance Trends, United States 2015–2017
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 12, p. 2112, doi. 10.1093/cid/ciaa381
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections – SMART United States 2018–2019.
- Published in:
- BMC Microbiology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12866-021-02135-z
- By:
- Publication type:
- Article
Factors Influencing Fluoroquinolone Resistance.
- Published in:
- 2003
- By:
- Publication type:
- Letter
Clostridium difficile Culture-Positive Toxin-Negative Diarrhea.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1986, v. 81, n. 10, p. 940
- By:
- Publication type:
- Article
Baseline in vitro Activity of Tigecycline among Key Bacterial Pathogens Exhibiting Multidrug Resistance.
- Published in:
- Chemotherapy (0009-3157), 2008, v. 54, n. 2, p. 91, doi. 10.1159/000118660
- By:
- Publication type:
- Article
The Activity of Levofloxacin and Comparator Agents against Clinical Isolates of Streptococcus pneumoniae Collected Worldwide during 1999 and 2000.
- Published in:
- Chemotherapy (0009-3157), 2002, v. 48, n. 5, p. 232, doi. 10.1159/000066769
- By:
- Publication type:
- Article
Ceftolozane/Tazobactam and Imipenem/Relebactam Cross-Susceptibility Among Clinical Isolates of Pseudomonas aeruginosa From Patients With Respiratory Tract Infections in ICU and Non-ICU Wards—SMART United States 2017–2019.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab320
- By:
- Publication type:
- Article
724. The In Vitro Activity of Gepotidacin and Comparator Agents Against Anaerobic Bacterial Isolates.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S325, doi. 10.1093/ofid/ofz360.792
- By:
- Publication type:
- Article
718. Activity of Ceftolozane–Tazobactam and Ceftazidime–Avibactam Against Clinical P. aeruginosa Isolates Collected in United States and Canada—SMART 2018.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S323, doi. 10.1093/ofid/ofz360.786
- By:
- Publication type:
- Article
706. In Vitro Activity of Ceftazidime–Avibactam and Comparator Agents Against MDR Enterobacteriaceae and Pseudomonas aeruginosa Collected in Latin America During the ATLAS Global Surveillance Program 2016–2017.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S318, doi. 10.1093/ofid/ofz360.774
- By:
- Publication type:
- Article
696. Cefiderocol Susceptibility Against Molecularly Characterized Carbapenemase-Producing Gram-Negative Bacteria in North America and Europe Between 2014 and 2017: SIDERO-WT-2014 to -2016 Studies.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S315, doi. 10.1093/ofid/ofz360.764
- By:
- Publication type:
- Article
693. In Vitro Activity of Ceftazidime–Avibactam and Comparator Agents Against Enterobacteriaceae and Pseudomonas aeruginosa Collected From Patients with Bloodstream Infections as Part of the ATLAS Global Surveillance Program, 2014–2017.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S314, doi. 10.1093/ofid/ofz360.761
- By:
- Publication type:
- Article
692. In Vitro Antibacterial Activity of Cefiderocol Against a Multi-national Collection of Carbapenem-Nonsusceptible Gram-Negative Bacteria From Respiratory Infections: SIDERO-WT-2014–2017.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S313, doi. 10.1093/ofid/ofz360.760
- By:
- Publication type:
- Article
680. In vitro Activity of Ceftazidime–Avibactam and Comparator Agents Against Pseudomonas aeruginosa from ICU and Non-ICU Wards Collected in Latin America and Globally as Part of the ATLAS Surveillance Program 2016–2017.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S310, doi. 10.1093/ofid/ofz360.748
- By:
- Publication type:
- Article
679. In vitro Activity of Cefiderocol (CFDC), a Novel Siderophore Cephalosporin, Against Difficult-to-Treat-Resistant (DTR) Gram-Negative Bacterial Pathogens From the Multi-National Sentinel Surveillance Study, SIDERO-WT (2014–2017).
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S309, doi. 10.1093/ofid/ofz360.747
- By:
- Publication type:
- Article
597. Cross-resistance of Ceftolozane-Tazobactam and Imipenem-Relebactam Against Clinical P. aeruginosa Isolates: SMART United States 2016–2018.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S281, doi. 10.1093/ofid/ofz360.666
- By:
- Publication type:
- Article
Nosocomial Outbreak of Gastroenteritis Due to Salmonella senftenberg.
- Published in:
- Clinical Infectious Diseases, 1996, v. 23, n. 4, p. 734, doi. 10.1093/clinids/23.4.734
- By:
- Publication type:
- Article
Gamma-glutamyltranspeptidase levels as an aid in the management of human cancer.
- Published in:
- 1983
- By:
- Publication type:
- journal article
Pharmacodynamic evaluation of i.v. antimicrobials against Pseudomonas aeruginosa samples collected from U.S. hospitals.
- Published in:
- American Journal of Health-System Pharmacy, 2011, v. 68, n. 17, p. 1619, doi. 10.2146/ajhp100569
- By:
- Publication type:
- Article
Antimicrobial resistance trends among sinus isolates of Streptococcus pneumoniae in the United States (2001–2005)
- Published in:
- Otolaryngology-Head & Neck Surgery, 2007, v. 136, n. 3, p. 385, doi. 10.1016/j.otohns.2006.09.016
- By:
- Publication type:
- Article
Recent trends in resistance to cell envelope-active antibacterial agents among key bacterial pathogens.
- Published in:
- Annals of the New York Academy of Sciences, 2013, v. 1277, n. 1, p. 1, doi. 10.1111/nyas.12022
- By:
- Publication type:
- Article
In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 1, p. 116, doi. 10.1093/jac/dkn124
- By:
- Publication type:
- Article
Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07: laboratory-based surveillance study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 62, n. 1, p. 109, doi. 10.1093/jac/dkn149
- By:
- Publication type:
- Article
In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 3, p. 595, doi. 10.1093/jac/dkm492
- By:
- Publication type:
- Article
Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999–2003).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2006, v. 57, n. 3, p. 437, doi. 10.1093/jac/dki487
- By:
- Publication type:
- Article
Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000-2001: a comparison with other beta-lactam agents.
- Published in:
- 2003
- By:
- Publication type:
- research
Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Stable Antimicrobial Susceptibility Rates for Clinical Isolates of Pseudomonas aeruginosa from the 2001- 2003 Tracking Resistance in the United States Today Surveillance Studies.
- Published in:
- Clinical Infectious Diseases, 2005, v. 40, p. S89, doi. 10.1086/426188
- By:
- Publication type:
- Article
Factors Associated with Relative Rates of Antimicrobial Resistance among Streptococcus pneumoniae in the United States: Results from the TRUST Surveillance Program (1998-2002).
- Published in:
- Clinical Infectious Diseases, 2003, v. 36, n. 8, p. 963, doi. 10.1086/374052
- By:
- Publication type:
- Article
Susceptibility of Antimicrobial-Resistant Urinary Escherichia coli Isolates to Fluoroquinolones and Nitrofurantoin.
- Published in:
- Clinical Infectious Diseases, 2003, v. 36, n. 2, p. 183, doi. 10.1086/345754
- By:
- Publication type:
- Article
Regional Trends in Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST Surveillance Program, 1999--2000.
- Published in:
- Clinical Infectious Diseases, 2002, v. 34, p. S4, doi. 10.1086/324525
- By:
- Publication type:
- Article
Antimicrobial Resistance Among Uropathogens that Cause Community-Acquired Urinary Tract Infections in Women: A Nationwide Analysis.
- Published in:
- Clinical Infectious Diseases, 2001, v. 33, n. 1, p. 89, doi. 10.1086/320880
- By:
- Publication type:
- Article
Antimicrobial Resistance in Key Bloodstream Bacterial Isolates: Electronic Surveillance with The Surveillance Network Database--USA.
- Published in:
- Clinical Infectious Diseases, 1999, v. 29, n. 2, p. 259, doi. 10.1086/520195
- By:
- Publication type:
- Article
In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018‒2020.
- Published in:
- Brazilian Journal of Infectious Diseases, 2023, v. 27, n. 3, p. 1, doi. 10.1016/j.bjid.2023.102775
- By:
- Publication type:
- Article
Epidemiology and in vitro activity of ceftazidimeavibactam and comparator agents against multidrugresistant isolates of Enterobacterales and Pseudomonas aeruginosa collected in Latin America as part of the ATLAS surveillance program in 2015‒2020.
- Published in:
- Brazilian Journal of Infectious Diseases, 2023, v. 27, n. 3, p. 1, doi. 10.1016/j.bjid.2023.102759
- By:
- Publication type:
- Article
In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017-2019.
- Published in:
- Brazilian Journal of Infectious Diseases, 2021, v. 25, n. 6, p. 1, doi. 10.1016/j.bjid.2021.101647
- By:
- Publication type:
- Article
Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013-2015.
- Published in:
- Brazilian Journal of Infectious Diseases, 2017, v. 21, n. 3, p. 343, doi. 10.1016/j.bjid.2017.03.006
- By:
- Publication type:
- Article
In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa.
- Published in:
- BMC Microbiology, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12866-019-1522-7
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam and imipenem/relebactam against Gram-negative clinical isolates collected in Mexico—SMART 2017–2021.
- Published in:
- JAC-Antimicrobial Resistance, 2024, v. 6, n. 3, p. 1, doi. 10.1093/jacamr/dlae077
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam, imipenem/relebactam and ceftazidime/avibactam against clinical Gram-negative isolates—SMART United States 2019–21.
- Published in:
- JAC-Antimicrobial Resistance, 2024, v. 6, n. 1, p. 1, doi. 10.1093/jacamr/dlad152
- By:
- Publication type:
- Article
Susceptibility of Gram-negative isolates collected in South Korea to imipenem/relebactam and comparator agents—SMART 2018–21.
- Published in:
- JAC-Antimicrobial Resistance, 2024, v. 6, n. 1, p. 1, doi. 10.1093/jacamr/dlad149
- By:
- Publication type:
- Article
Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical isolates of Enterobacterales and Pseudomonas aeruginosa collected in central and northern Europe (Belgium, Norway, Sweden, Switzerland)--SMART 2017-21.
- Published in:
- JAC-Antimicrobial Resistance, 2023, v. 5, n. 4, p. 1, doi. 10.1093/jacamr/dlad098
- By:
- Publication type:
- Article
Susceptibility profile and β-lactamase content of global Pseudomonas aeruginosa isolates resistant to ceftolozane/tazobactam and/or imipenem/relebactam--SMART 2016-21.
- Published in:
- JAC-Antimicrobial Resistance, 2023, v. 5, n. 3, p. 1, doi. 10.1093/jacamr/dlad080
- By:
- Publication type:
- Article
In vitro activity of imipenem/relebactam against piperacillin/tazobactam-resistant and meropenem-resistant non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa collected from patients with lower respiratory tract infections in Western Europe: SMART 2018-20
- Published in:
- JAC-Antimicrobial Resistance, 2023, v. 5, n. 1, p. 1, doi. 10.1093/jacamr/dlad003
- By:
- Publication type:
- Article
Carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa causing infection in Africa and the Middle East: a surveillance study from the ATLAS programme (2018-20).
- Published in:
- JAC-Antimicrobial Resistance, 2022, v. 4, n. 3, p. 1, doi. 10.1093/jacamr/dlac060
- By:
- Publication type:
- Article
Trends in Antibiotic Resistance Among Ocular Microorganisms in the United States From 2009 to 2018.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Antibiotic Resistance Among Ocular Pathogens in the United States: Five-Year Results From the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study.
- Published in:
- 2015
- By:
- Publication type:
- journal article